GLP-1 Provider Comparison

MEDVi vs PlexusDx: GLP-1 prices and programs compared

Part of our GLP-1 provider research: See how every compounded tirzepatide provider compares →

MEDVi's ongoing rate is $299 a month for semaglutide and $399 for tirzepatide. PlexusDx charges one flat, all-inclusive $189 — $289 for tirzepatide — the same every month, at every dose. MEDVi's edges are a longer prepaid ladder with 0% financing and more included support; PlexusDx's are the lower ongoing rate, commitment discounts, and a cheaper oral option.

Month-to-month, all-in
PlexusDx$189 / $289, the same every month at every dose
MEDVi$299 / $399 ongoing
Cost over 12 months, ongoing rate
PlexusDx$2,268 / $3,468
MEDVi$3,588 / $4,788
Lower rates for committing
PlexusDx$169 / $269 (3-month) · $149 / $249 (6-month), all published
MEDVi3-, 6- and 12-month bundles with 0% financing
Included support
PlexusDxfree check-in with a Doctor of Pharmacy; optional genetics add-on
MEDVifree care coaching, free dietitian visit, unlimited doctor calls
Formats, and the oral option
PlexusDxinjection, oral, combination, $129 microdose; oral costs less
MEDViinjection or oral tablet (+$70 over its injection)
Pricing visible before intake
PlexusDxevery tier published
MEDViprice shown after its health questionnaire

Green marks the better result on that row, for either program.

Prices verified July 20, 2026 · MEDVi figures from its own signup flow · semaglutide first, tirzepatide second

Is MEDVi or PlexusDx better?

MEDVi's ongoing rate is $299/$399 month-to-month. PlexusDx is a flat $189/$289 month-to-month, with 3- and 6-month rates down to $149/$249.

‹ Compare all GLP-1 providers

Bottom line

Month-to-month, PlexusDx is $110 less on both compounds — $189 and $289 against MEDVi's ongoing $299 and $399, or $1,320 less across a year on either. What should decide it: whether you want the lower ongoing rate, a cheaper oral option, and pricing you can see before a questionnaire, or MEDVi's longer prepaid ladder with 0% financing and its generous included coaching, dietitian visit and unlimited doctor calls.

Choose MEDVi if…
  • You want the longest prepaid commitment available. MEDVi sells 3-, 6- and 12-month bundles, reaching a 48-week term; our deepest is six months. We are not publishing MEDVi's bundle rates — see the note below the pricing tables.
  • You want 0% financing on a bundle. MEDVi's multi-month plans offer Klarna instalments spread over 12 months, with MEDVi stating it is "not a party" to that agreement.
  • You value generous included support. MEDVi bundles free care coaching, a free dietitian visit, and unlimited doctor calls — more included contact than we offer.
Choose PlexusDx if…
  • You want one flat, all-inclusive price. $189/$289 covers the consult, prescription, medication and shipping — the same every month, at every dose.
  • You want a lower rate for committing. $169/$269 on 3 months or $149/$249 on 6, every tier published on the product page before you start.
  • You want a cheaper oral option, or more formats. MEDVi offers an oral tablet too, but it runs about $70 over its injection; PlexusDx's oral costs less, and we also add the GLP-Squared combination and a $129 microdose.
  • You want optional genetics and pharmacist support. An optional genetics add-on ($298, or $99 for program members) and a free check-in with a Doctor of Pharmacy. The test does not select or predict a medication — your provider decides.
Our scorecardPlexusDx 4.5/5 · MEDVi 3.4/5
Criterion PlexusDx MEDVi
Ongoing month-to-month price ($189/$289 flat vs $299/$399)5.02.5
Commitment options (3- and 6-month rates, all published, vs 3-, 6- and 12-month bundles with 0% financing)4.04.0
Flexibility to stop / refund terms (both cancel-anytime monthly; MEDVi bundles non-refundable for unused months)4.03.5
Formats & options (injection, oral, combination + $129 microdose vs injection or oral tablet)5.03.5
Included support & extras (named PharmD + optional genetics vs dietitian + coaching + unlimited doctor calls)4.54.0
Pricing published before intake (every tier published vs price shown after the questionnaire)4.53.0

Our own opinion scoring by the PlexusDx editorial team against each program's July 2026 captured pricing and published offerings, not customer ratings. Six criteria, each scored out of 5; the figure shown is the average. MEDVi scores level with us on commitment options, on the strength of a longer 12-month ladder with 0% financing, and higher than us on included support. We publish this comparison and are one of its two programs.

How much do MEDVi and PlexusDx cost per month and per year? (Verified July 2026)

MEDVi's ongoing rate is $299/month for semaglutide and $399 for tirzepatide. PlexusDx is a flat $189/$289 month-to-month — $169/$269 on 3 months, $149/$249 on 6.

Month-to-month, PlexusDx is $110/month less on both compounds — $189 and $289 against MEDVi's ongoing $299 and $399 — and about $1,320 less over a year on each. MEDVi's own advantages are structural rather than price: it sells a longer prepaid ladder, out to a 48-week commitment with 0% financing, and it includes more contact — care coaching, a dietitian visit and unlimited doctor calls.

Semaglutide — by termPlexusDxMEDViDifference
Month-to-month (ongoing)$189/mo, one charge$299/mo ongoingPlexusDx −$110/mo
Lower rate for committing$169/mo (3-month) · $149/mo (6-month)3-, 6- and 12-month bundles, with 0% financingNot compared — see the note below
Cost over 12 months, ongoing rate$2,268 (12 × $189)$3,588 (12 × $299)PlexusDx −$1,320/yr
Tirzepatide — by termPlexusDxMEDViDifference
Month-to-month (ongoing)$289/mo, one charge$399/mo ongoingPlexusDx −$110/mo
Lower rate for committing$269/mo (3-month) · $249/mo (6-month)3-, 6- and 12-month bundles, with 0% financingNot compared — see the note below
Cost over 12 months, ongoing rate$3,468 (12 × $289)$4,788 (12 × $399)PlexusDx −$1,320/yr

Running totals: who's cheaper, and when

On each program's ongoing monthly rate, PlexusDx costs $110 less every month on both compounds — $189 against MEDVi's $299, and $289 against its $399 — and the gap compounds across a year.

  • Monthly plan, semaglutide, year one: MEDVi $3,588 (12 × $299) vs PlexusDx $2,268 (12 × $189) — PlexusDx $1,320 cheaper.
  • Monthly plan, tirzepatide, year one: MEDVi $4,788 (12 × $399) vs PlexusDx $3,468 (12 × $289) — PlexusDx $1,320 cheaper.
  • Our own six-month rate, for reference: twelve months at $149/$249 comes to $1,788 semaglutide and $2,988 tirzepatide. That is a different commitment from a month-to-month plan, so we do not set it against MEDVi's monthly rate.

What we are not publishing for MEDVi, and why

MEDVi sells 3-, 6- and 12-month prepaid bundles, and we completed its signup far enough to reach two rendered order summaries. We are still not putting a per-month figure for those bundles on this page.

We compare a competitor's prepaid tier only against its standard rate for that tier, and we could not establish MEDVi's to our own evidence standard. Rather than publish a number we cannot stand behind — in either direction, including where it would have flattered us — we leave MEDVi's prepaid ladder out of the comparison entirely, and will add it if a future capture settles it. The month-to-month rates above are MEDVi's own regular rates and are unaffected.

How MEDVi's billing works

  • Auto-renewing subscription: the monthly plan enrolls you in an auto-renewing subscription, charged "at the specified recurring intervals until I cancel."
  • Supply label, not a billing cycle: the monthly plan ships a "4 Week Supply" — how much medication arrives per shipment, not a stated billing interval; MEDVi describes the plan as monthly and auto-renewing.
  • No membership fee: MEDVi charges no separate membership — parity with PlexusDx, which also has none.
  • Multi-month bundles are prepaid: paid upfront or through Klarna 0% financing over 12 months; MEDVi states multi-month packages "will not be refunded for unused medication or remaining months."
  • Binding, final transaction: MEDVi's checkout consent states the order is "a binding, final transaction," that refunds are available only as stated in its Refund Policy, that cancellation fees may apply, and that cancelling "only stops future charges."

MEDVi billing language quoted verbatim from its checkout order summaries and plan-selection screens, captured July 20, 2026.

MEDVi figures recorded by completing its signup on July 20, 2026 (19 dated captures) through its health questionnaire, both plan-selection screens and two rendered checkout order summaries. The month-to-month rates shown here are MEDVi's own regular rates, read from its plan-selection screens. PlexusDx figures are our published all-inclusive rates; paired figures list semaglutide first, tirzepatide second. Prices change often — check both sites.

One flat price of $189 or $289, the same every month it renews

Semaglutide $189/mo, tirzepatide $289/mo, all-inclusive and the same at every dose — covering the consult, prescription, medication and shipping, and down to $149/$249 on a 6-month rate. A licensed provider reviews your intake before anything is prescribed.

Start your intake

How do PlexusDx and MEDVi compare, feature by feature?

Both are cash-pay compounded-GLP-1 programs selling semaglutide and tirzepatide, each in injection and oral forms. PlexusDx bills one flat month-to-month charge of $189/$289; MEDVi's ongoing month-to-month rate is $299/$399, with deeper prepaid bundles.

FeaturePlexusDxMEDVi
Ongoing all-in monthly price$189 / $289$299 / $399
Billing structureOne flat, all-inclusive chargeMonthly, auto-renewing; multi-month plans prepaid
Required membership feeNoneNone
Lower rates for committingYes — $169/$269 (3-mo), $149/$249 (6-mo), all publishedYes — 3-, 6- and 12-month bundles, with 0% financing
Cost over 12 months, ongoing rate$2,268 / $3,468$3,588 / $4,788
Flat price at every doseYes — at every doseYes — "Same Price. All Dosage Levels."
Oral (no-injection) optionYes — oral sema & tirz, and cheaper than MEDVi'sYes — oral tablet, about +$70 over its injection
Combination GLP-1 protocolYes — GLP-SquaredNo
Lower-cost microdose entryYes — $129/moNo
Optional genetics add-onYes — $298, or $99 for membersNo
Free named-pharmacist check-inYes — Dr. Jayden Lee, PharmDNo

Compiled from MEDVi's signup flow, plan-select screens and checkout order summaries as captured July 2026, alongside PlexusDx's published rates. Paired cells show semaglutide first, tirzepatide second.

When is MEDVi the better choice?

MEDVi is the better pick if you want the longest prepaid commitment available, financing to spread it, or its included dietitian and coaching.

  • It offers a longer prepaid ladder than we do. MEDVi sells 3-, 6- and 12-month bundles, reaching a 48-week term; our deepest is six months. We are not publishing MEDVi's bundle rates — see the note under the pricing tables in the previous section.
  • Generous inclusions. A free dietitian visit, free care coaching, and "UNLIMITED doctor calls 7 days a week" are bundled into every plan — more included contact than PlexusDx offers.
  • It offers Klarna 0% financing to spread multi-month plans over 12 months, noting it is "not a party" to that agreement.

When is PlexusDx the better choice?

PlexusDx is the better pick if you want a lower ongoing price, one flat all-inclusive charge, more ways to take the medication, or the genetics and pharmacist layer.

  • Flat month-to-month. $189 semaglutide and $289 tirzepatide is one all-inclusive charge, the same every month at every dose, covering the consult, prescription, medication and shipping.
  • A lower ongoing rate. On the ongoing month-to-month rate PlexusDx is $110/month below MEDVi — $189 against $299, and $289 against $399.
  • More ways to take it — and a cheaper oral. The GLP-Squared combination and a $129 microdose are formats MEDVi doesn't offer; MEDVi has an oral tablet too, but it runs about $70 over its injection, and PlexusDx's oral costs less.
  • Published pricing, plus genetics and a pharmacist. Every tier is shown before intake, alongside the optional Precision Peptide Genetic Test ($298, or $99 for program members) and a free check-in with Dr. Jayden Lee, PharmD. It does not select or predict a medication; your provider decides.
Availability

What does PlexusDx offer that MEDVi doesn't?

Both programs offer an oral option alongside injections, so oral isn't the dividing line — but PlexusDx's oral costs less than MEDVi's, and PlexusDx adds three formats MEDVi doesn't: the GLP-Squared combination protocol, GLP-Squared Oral, and a $129 microdose.

  • Injection is where PlexusDx undercuts MEDVi. Semaglutide injection is $189/month month-to-month — $110 under MEDVi's $299 ongoing rate.
  • Both offer an oral tablet — ours costs less. MEDVi's tablet runs about $70 over its own injection; PlexusDx's oral runs below MEDVi's on the ongoing rate.
  • Within PlexusDx, oral is a premium over injection — oral semaglutide is $289/month month-to-month, a no-injection format priced above our own injection, offered alongside it rather than instead of it.

PlexusDx GLP-1 formats and published pricing, month-to-month first

How does MEDVi pricing work?

MEDVi's ongoing month-to-month rate is $299 semaglutide / $399 tirzepatide, with no membership fee. It also sells 3-, 6- and 12-month prepaid bundles, whose rates we are not publishing.

Plan lengthsMonthly · 3 · 6 · 12 months — the multi-month plans are single prepaid bundles
Ongoing month-to-month$299/mo sema · $399/mo tirz — what the Monthly plan bills each month
Cost over 12 months$3,588 sema · $4,788 tirz — twelve months at the ongoing rate
Prepaid bundle ratesNot published here — a longer ladder than ours; rates not established
Membership feeNone — "No membership or hidden fees"
Dose pricingSame price at every dose — "Same Price. All Dosage Levels."
BillingMonthly, auto-renewing — multi-month plans are single prepaid bundles
Shipping & financingFree shipping · Klarna 0% — 0% financing over 12 months on multi-month plans

MEDVi describes its billing in its own checkout terms. In its own words, enrolling authorizes:

  • an "auto-renewing subscription," charged "at the specified recurring intervals until I cancel";
  • a "binding, final transaction," with refunds "governed solely by the MEDVi Refund Policy";
  • "cancellation only stops future charges"; and
  • "multi-month packages will not be refunded for unused medication or remaining months."

How does PlexusDx pricing work?

PlexusDx charges one flat, all-inclusive price per medication, the same at every dose — semaglutide $189/mo and tirzepatide $289/mo month-to-month, dropping to $149/$249 on a 6-month plan.

Month-to-month$189/mo sema · $289/mo tirz — the same at every dose
3-month rate$169/mo sema · $269/mo tirz — on the 3-month plan
6-month rate$149/mo sema · $249/mo tirz — on the 6-month plan
Membership feeNone — one charge covers the consult, prescription, medication & shipping
Microdose entry$129/mo flat — a lower-cost entry point, priced the same way
Pricing published up frontEvery tier shown before intake — MEDVi's price appears after the questionnaire

Where PlexusDx holds its rate is over time — one flat charge, the same every month at every dose. Compared on each program's ongoing monthly rate, across a full year:

  • Semaglutide, monthly plan, year one: $2,268 at PlexusDx's flat $189 vs $3,588 at MEDVi's ongoing rate (12 × $299) — $1,320 less.
  • Tirzepatide, monthly plan, year one: $3,468 at PlexusDx's flat $289 vs $4,788 (12 × $399) — $1,320 less.
  • Our own six-month rate, for reference: twelve months at $149/$249 comes to $1,788 semaglutide and $2,988 tirzepatide. That is a different commitment from a month-to-month plan, so we do not set it against MEDVi's monthly rate.
  • MEDVi's prepaid bundles are not in this comparison. We compare a competitor's prepaid tier only against its standard rate for that tier, and we could not establish MEDVi's to our own evidence standard, so we leave it out rather than publish a figure we cannot stand behind.

How does compounded GLP-1 telehealth work?

You complete an online intake, a licensed provider reviews it, and if treatment is appropriate a state-licensed 503A pharmacy prepares and ships your medication — no in-person visit required.

Both PlexusDx and MEDVi follow this cash-pay telehealth model. You answer a health questionnaire online; a licensed U.S. provider reviews your history and, if appropriate, writes a prescription. A 503A compounding pharmacy — a state-licensed facility that prepares medication for an individual patient based on a valid prescription — fills it and ships it to your door.

  • Who's eligible: typically adults with a BMI of 27 or higher, or a weight-related health condition, confirmed during intake.
  • Who sets the dose: your provider selects your starting dose and adjusts it over time — you don't choose your own.
  • What titration costs: nothing extra at PlexusDx — one rate at every dose level. MEDVi likewise states "Same Price. All Dosage Levels."
  • Questions: at PlexusDx you can bring any to your free check-in with Dr. Jayden Lee, PharmD.

Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, quality, or effectiveness. They are a legal, provider-prescribed option prepared by a licensed pharmacy — not a generic or a substitute the FDA has evaluated.

The PlexusDx difference

Does either program look at your biology or include pharmacist support?

Neither program includes a DNA-based test as part of its GLP-1 program. PlexusDx offers one as an optional add-on — $298, or $99 for program members.

The optional Precision Peptide Genetic Test gives you and your licensed provider added clarity on how your body is wired. The idea is simple: know your biology, don't guess at it.

  • What it reads: how your genes influence weight-management-related pathways — the biology behind appetite, metabolism, and how your body handles fats and carbohydrates.
  • Price: $298, or $99 for program members.
  • What it isn't: it does not select or predict a medication; your provider decides — and it won't predict how you'll respond. It's context, not a prescription.
Included: a free check-in with Dr. Jayden Lee, PharmD

Every PlexusDx prescription includes a free 15-minute check-in with our Medical Director and Doctor of Pharmacy — by video or phone — to talk through medication questions, side effects, and how your protocol is going. It's education and support; your licensed provider still makes every prescribing decision.

How did we verify these prices?

We completed MEDVi's full signup on July 20, 2026, from the first health question through both plan-selection screens to two rendered checkout order summaries. Every MEDVi figure on this page comes from that capture.

Ongoing monthly rate$299 / $399 semaglutide / tirzepatide, month-to-month
PlexusDx published rate$189 / $289 month-to-month, down to $149 / $249 on 6 months
Cost over 12 months$3,588 / $4,788 twelve months at MEDVi's ongoing rate
Prepaid bundle ratesNot published 3-, 6- and 12-month terms exist; rates not established

Method. We went through MEDVi's intake from the first health question to two rendered checkout order summaries on July 20, 2026 — 19 dated captures covering the twelve-screen questionnaire, both plan-selection screens (semaglutide and tirzepatide), and the two checkouts. Those captures are the source for every MEDVi figure on this page; we did not take any MEDVi price from a third-party review site or aggregator.

We compare published regular rates. Promotional offers are common across this category — ours included — and they change too often to compare fairly, so we exclude them on both sides.

What we could not verify, and left out. Three things. MEDVi's ongoing Monthly-plan rate — $299 semaglutide, $399 tirzepatide — was read from its plan-selection cards rather than from a rendered order summary; it is MEDVi's own regular rate, struck through on the card, and it is the only MEDVi price we publish. MEDVi's prepaid bundle rates are not on this page at all: we compare a competitor's prepaid tier only against its standard rate for that tier, and we could not establish MEDVi's to our own evidence standard, so we withdrew every bundle figure rather than publish one we cannot stand behind — in either direction, including where it would have flattered us. And MEDVi's oral tablet — a flat +$70 over its injection for both compounds, confirmed on a later plan-selection screen — was read there rather than at a rendered checkout, so we cite the +$70 upcharge but publish no specific MEDVi tablet monthly total.

A note on who wrote this. PlexusDx publishes this page and is one of the two programs compared, so we are not a neutral party. That's why we used MEDVi's own plan-selection and checkout screens as the only source for its figures, and why we state plainly where MEDVi beats us. Category pricing changes often; check both sites before you decide.

  • MEDVi offers a longer prepaid ladder than we do. It sells 3-, 6- and 12-month bundles, reaching a 48-week term; our deepest is six months.
  • MEDVi offers 0% financing. Klarna instalments spread multi-month plans over 12 months; we do not offer financing.
  • MEDVi's inclusions are generous. Free care coaching, a free dietitian visit, board-certified physician review, and unlimited doctor calls seven days a week — more included contact than we offer.
  • MEDVi is a clean operator. It charges no membership fee, holds one price across every dose, and ships free — parity with us on the first two — and it states its auto-renewal and refund terms plainly at checkout.
Sources: MEDVi signup, plan-selection and checkout flow, captured in full July 20, 2026 (19 dated screenshots on file), covering its twelve-screen health questionnaire, both plan-selection screens and two rendered checkout order summaries. The MEDVi rates published here are its ongoing month-to-month rates, read from those plan-selection screens. PlexusDx published pricing tiers (verified July 2026). MEDVi's plan terms and inclusions are quoted from its own plan-selection and checkout screens. Figures reflect the verification dates; prices in this category change often.

See your PlexusDx price. One flat, all-inclusive charge.

One published price covering the provider consult, prescription, medication and shipping — no separate membership — with 3- and 6-month rates if you want them. Semaglutide $189/mo, tirzepatide $289/mo. A licensed provider reviews your intake before anything is prescribed.

Start your intake

Frequently Asked Questions

What is compounded GLP-1?

Compounded GLP-1 medications are semaglutide or tirzepatide prepared for an individual patient by a state-licensed 503A compounding pharmacy on a valid prescription. They are not FDA-approved. Both MEDVi and PlexusDx operate in this category.

  • Not FDA-reviewed. Compounded medications are not reviewed by the FDA for safety, quality, or effectiveness.
  • The approved versions. Only Novo Nordisk (semaglutide) and Lilly (tirzepatide) make FDA-approved branded products.

Is the compounded medication FDA-approved?

No — compounded medications are not FDA-approved and are not reviewed by the FDA for safety, quality, or effectiveness. They are prepared by a state-licensed 503A pharmacy for an individual patient on a valid prescription.

  • Semaglutide. Novo Nordisk is the only U.S. company with FDA-approved semaglutide (Wegovy®, Ozempic®, Rybelsus®).
  • Tirzepatide. Lilly is the only U.S. company with FDA-approved tirzepatide (Zepbound®, Mounjaro®).

Is PlexusDx cheaper than MEDVi?

On the ongoing month-to-month rate, yes — $189 versus $299 for semaglutide and $289 versus $399 for tirzepatide, a $110/month difference on both compounds. Over a year that is $1,320 less on each, and our 6-month rate takes it lower still.

  • On the Monthly plan over a year, PlexusDx runs $1,320 cheaper on both compounds — $2,268 versus $3,588 for semaglutide, $3,468 versus $4,788 for tirzepatide.
  • MEDVi's prepaid bundles are not part of this comparison. We compare a competitor's prepaid tier only against its standard rate for that tier, and we could not establish MEDVi's to our own evidence standard, so we publish no figure for them.

How much does MEDVi cost per month?

When we completed MEDVi's signup on July 20, 2026, its ongoing month-to-month rate was $299 for semaglutide and $399 for tirzepatide, with no membership fee and free shipping. That is MEDVi's own regular monthly rate, read from its plan-selection screens.

  • MEDVi also sells prepaid bundles on 3-, 6- and 12-month terms, with Klarna 0% financing spread over 12 months. We are not publishing a per-month figure for those tiers.
  • The price is shown after intake: no price appears on MEDVi's landing page or on any of its twelve health-questionnaire screens.

How much does MEDVi cost per year?

On MEDVi's Monthly plan, $3,588 for semaglutide and $4,788 for tirzepatide over twelve months at its ongoing rate. PlexusDx works out to $2,268 and $3,468 over the same twelve months, also month-to-month — $1,320 less on each. Our own 6-month rate comes to $1,788 and $2,988 over a year, but that is a different commitment and we do not set it against a monthly rate.

  • These are ongoing-rate figures, twelve months at $299 and $399. MEDVi's monthly plan is auto-renewing, and it does not print a billing interval on screen, so we do not annualize it any other way.
  • MEDVi's prepaid bundle totals are not published here — see how we verified these prices, above.

Does MEDVi charge a membership fee?

No — MEDVi states that all its plans include everything with no membership fee, and PlexusDx charges no membership either. Neither program adds a recurring fee on top of the medication price.

  • MEDVi's inclusions: board-certified physician review, free care coaching, a free dietitian visit, and unlimited doctor calls seven days a week.
  • PlexusDx's price covers the provider consult, prescription, medication, and shipping in one flat charge.

Does the price change as my dose increases?

No — PlexusDx charges the same price at every dose level, and MEDVi states the same policy: "Same Price. All Dosage Levels." Flat pricing at every dose is table stakes in this category — both programs offer it.

  • Why it matters: GLP-1 doses typically titrate upward over the first months; neither program raises its price as your dose increases.

Can I cancel anytime, or am I locked into a contract?

Both programs sell a monthly plan you can cancel: MEDVi's Monthly plan is an auto-renewing subscription you can cancel per its terms, and PlexusDx's month-to-month plan has no contract. Multi-month plans at both are prepaid commitments.

  • MEDVi's terms state that cancellation stops future charges and that multi-month packages "will not be refunded for unused medication or remaining months."
  • PlexusDx's 3- and 6-month rates involve a longer commitment for a lower price; its longest plan is 6 months. MEDVi's bundles run up to 12 months (48 weeks), with Klarna 0% financing available.

Which states is PlexusDx available in?

PlexusDx is available in most U.S. states where telehealth prescribing of these medications is permitted. You'll confirm whether your state is covered during intake. MEDVi operates on a similar state-by-state basis.

Is shipping included, and how does it work?

Yes — PlexusDx includes direct-to-door shipping in its monthly price, with no separate shipping fee. Your medication ships from a state-licensed 503A pharmacy in discreet packaging after your provider approves it. MEDVi's shipping is also free.

  • MEDVi's checkout showed shipping as free on both order summaries, alongside a "Prescribed & shipped within 48 hours" badge.

What are the common side effects, and what support is there?

The most common GLP-1 side effects are gastrointestinal — nausea and digestive changes — usually most noticeable when starting or increasing a dose. Your provider titrates your dose to manage tolerability. This page is not medical advice.

  • Every PlexusDx prescription includes a free 15-minute check-in with Dr. Jayden Lee, PharmD, for side-effect and medication questions.
  • MEDVi includes free care coaching, a free dietitian visit, and unlimited doctor calls seven days a week.
  • Discuss any symptoms with your provider.

Does PlexusDx offer anything MEDVi doesn't?

Four things stood out in our comparison: pricing published before intake, more formats — both GLP-Squared combinations and a $129/month microdose, plus an oral option that costs less than MEDVi's oral tablet — an optional genetics test, and a named PharmD check-in. MEDVi offers both injections and an oral tablet, with its pricing shown after its health questionnaire.

  • Every PlexusDx tier is published on its product pages before you start intake — $189/$289 month-to-month, down to $149/$249 on 6-month rates.
  • MEDVi counters with generous inclusions — a free dietitian visit, care coaching, unlimited doctor calls — and Klarna 0% financing.

What does the PlexusDx genetics test do?

It analyzes how your genes influence weight-management-related biological pathways, to inform your conversation with your provider. It does not select or predict a medication; your provider decides.

  • An optional add-on — $298, or $99 for program members. Neither program includes a DNA-based test as part of its GLP-1 program.
  • It does not recommend, prescribe, or determine which medication you should use, and it does not predict your response to any specific drug.

PlexusDx tells you about your biology. It does not tell you what to put in your body.

Important information about your prescription program. PlexusDx connects patients with an independent network of U.S.-licensed clinicians through a state-licensed telehealth platform. A prescription is issued only if a licensed provider determines it is appropriate. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, quality, or effectiveness. Novo Nordisk, Inc. is the only U.S. company with FDA-approved products containing semaglutide (Rybelsus®, Ozempic®, Wegovy®). Lilly USA, LLC is the only U.S. company with FDA-approved products containing tirzepatide (Zepbound®, Mounjaro®). Rybelsus®, Ozempic®, and Wegovy® are registered trademarks of Novo Nordisk, Inc.; Zepbound® and Mounjaro® are registered trademarks of Eli Lilly and Company. PlexusDx is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Inc. or Eli Lilly and Company. This page compares publicly available program information as of July 2026 and is updated periodically; prices and offerings may change. It is not medical advice — consult a qualified healthcare provider before beginning any treatment. Competitor names and prices are the property of their respective owners and are cited for comparison only.